Correlation Between SAB Biotherapeutics and Salarius Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both SAB Biotherapeutics and Salarius Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SAB Biotherapeutics and Salarius Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SAB Biotherapeutics and Salarius Pharmaceuticals, you can compare the effects of market volatilities on SAB Biotherapeutics and Salarius Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SAB Biotherapeutics with a short position of Salarius Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of SAB Biotherapeutics and Salarius Pharmaceuticals.
Diversification Opportunities for SAB Biotherapeutics and Salarius Pharmaceuticals
0.14 | Correlation Coefficient |
Average diversification
The 3 months correlation between SAB and Salarius is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and Salarius Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Salarius Pharmaceuticals and SAB Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAB Biotherapeutics are associated (or correlated) with Salarius Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Salarius Pharmaceuticals has no effect on the direction of SAB Biotherapeutics i.e., SAB Biotherapeutics and Salarius Pharmaceuticals go up and down completely randomly.
Pair Corralation between SAB Biotherapeutics and Salarius Pharmaceuticals
Given the investment horizon of 90 days SAB Biotherapeutics is expected to generate 0.68 times more return on investment than Salarius Pharmaceuticals. However, SAB Biotherapeutics is 1.46 times less risky than Salarius Pharmaceuticals. It trades about -0.15 of its potential returns per unit of risk. Salarius Pharmaceuticals is currently generating about -0.32 per unit of risk. If you would invest 217.00 in SAB Biotherapeutics on December 1, 2024 and sell it today you would lose (46.00) from holding SAB Biotherapeutics or give up 21.2% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
SAB Biotherapeutics vs. Salarius Pharmaceuticals
Performance |
Timeline |
SAB Biotherapeutics |
Salarius Pharmaceuticals |
SAB Biotherapeutics and Salarius Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with SAB Biotherapeutics and Salarius Pharmaceuticals
The main advantage of trading using opposite SAB Biotherapeutics and Salarius Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SAB Biotherapeutics position performs unexpectedly, Salarius Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Salarius Pharmaceuticals will offset losses from the drop in Salarius Pharmaceuticals' long position.SAB Biotherapeutics vs. Processa Pharmaceuticals | SAB Biotherapeutics vs. Third Harmonic Bio | SAB Biotherapeutics vs. Cingulate Warrants | SAB Biotherapeutics vs. Anebulo Pharmaceuticals |
Salarius Pharmaceuticals vs. Akari Therapeutics PLC | Salarius Pharmaceuticals vs. Nutriband | Salarius Pharmaceuticals vs. SAB Biotherapeutics | Salarius Pharmaceuticals vs. GeoVax Labs |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Complementary Tools
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Content Syndication Quickly integrate customizable finance content to your own investment portal |